Literature DB >> 19525336

Statistical treatment of fluorescence in situ hybridization validation data to generate normal reference ranges using Excel functions.

Allison L Ciolino1, Mary E Tang, Ron Bryant.   

Abstract

Fluorescent in situ hybridization has become an essential tool for diagnosing and monitoring hematological disease. Testing for minimal residual disease requires precise and accurate normal cut-offs. There is no consensus in the field on the correct method of establishing a normal reference range. We discuss and compare several proposed statistical methods to calculate normal reference ranges, including Gaussian statistics, the beta inverse function, and a binomial treatment of the data. We demonstrate that a binomial treatment of the data is an accurate and simple method to calculate a normal reference range.

Entities:  

Mesh:

Year:  2009        PMID: 19525336      PMCID: PMC2710710          DOI: 10.2353/jmoldx.2009.080101

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN: 1525-1578            Impact factor:   5.568


  7 in total

1.  A multicenter investigation with D-FISH BCR/ABL1 probes.

Authors:  G Dewald; R Stallard; A Alsaadi; S Arnold; R Blough; T M Ceperich; B Rafael Elejalde; J Fink; J V Higgins; R R Higgins; G A Hoeltge; W T Hsu; E B Johnson; D Kronberger; D J McCorquodale; L F Meisner; M A Micale; L Oseth; J S Payne; S Schwartz; S Sheldon; A Sophian; P Storto; P Van Tuinen; G D Wenger; A Wiktor; L A Willis; J F Yung; J Zenger-Hain
Journal:  Cancer Genet Cytogenet       Date:  2000-01-15

Review 2.  Fluorescent in situ hybridization in the diagnosis, prognosis, and treatment monitoring of chronic myeloid leukemia.

Authors:  Andrew P Landstrom; Ayalew Tefferi
Journal:  Leuk Lymphoma       Date:  2006-03

3.  Guidance for fluorescence in situ hybridization testing in hematologic disorders.

Authors:  Daynna J Wolff; Adam Bagg; Linda D Cooley; Gordon W Dewald; Betsy A Hirsch; Peter B Jacky; Kathleen W Rao; P Nagesh Rao
Journal:  J Mol Diagn       Date:  2007-04       Impact factor: 5.568

4.  Highly sensitive fluorescence in situ hybridization method to detect double BCR/ABL fusion and monitor response to therapy in chronic myeloid leukemia.

Authors:  G W Dewald; W A Wyatt; A L Juneau; R O Carlson; A R Zinsmeister; S M Jalal; J L Spurbeck; R T Silver
Journal:  Blood       Date:  1998-05-01       Impact factor: 22.113

Review 5.  Molecular diagnosis and monitoring in the clinical management of patients with chronic myelogenous leukemia treated with tyrosine kinase inhibitors.

Authors:  Joyce Ou; Jo-Anne Vergilio; Adam Bagg
Journal:  Am J Hematol       Date:  2008-04       Impact factor: 10.047

6.  A case of chronic myelogenous leukemia with e8a2 fusion transcript.

Authors:  Il Joong Park; Young Ae Lim; Wee Gyo Lee; Joon Seong Park; Hugh Chul Kim; Hyeon-Ji Lee; Sung Ran Cho
Journal:  Cancer Genet Cytogenet       Date:  2008-09

7.  Preclinical validation of fluorescence in situ hybridization assays for clinical practice.

Authors:  Anne E Wiktor; Daniel L Van Dyke; Peggy J Stupca; Rhett P Ketterling; Erik C Thorland; Brandon M Shearer; Stephanie R Fink; Kimberly J Stockero; Jason R Majorowicz; Gordon W Dewald
Journal:  Genet Med       Date:  2006-01       Impact factor: 8.822

  7 in total
  4 in total

1.  Target fluorescence in-situ hybridization (Target FISH) for plasma cell enrichment in myeloma.

Authors:  Edmond S K Ma; Candy L N Wang; Anthony T C Wong; Gigi Choy; Tsun Leung Chan
Journal:  Mol Cytogenet       Date:  2016-08-16       Impact factor: 2.009

2.  Clinical significance of cytogenetic aberrations in bone marrow of patients with diffuse large B-cell lymphoma: prognostic significance and relevance to histologic involvement.

Authors:  Seon Kim; Hyo Kim; Hye Kang; Jin Kim; Hyeon Eom; Tae Kim; Sung-Soo Yoon; Cheolwon Suh; Dong Lee
Journal:  J Hematol Oncol       Date:  2013-10-03       Impact factor: 17.388

3.  Subtyping of renal cortical neoplasms in fine needle aspiration biopsies using a decision tree based on genomic alterations detected by fluorescence in situ hybridization.

Authors:  Banumathy Gowrishankar; Lynnette Cahill; Alexandra E Arndt; Hikmat Al-Ahmadie; Oscar Lin; Kalyani Chadalavada; Seeta Chaganti; Gouri J Nanjangud; Vundavalli V Murty; Raju S K Chaganti; Victor E Reuter; Jane Houldsworth
Journal:  BJU Int       Date:  2014-07-15       Impact factor: 5.588

Review 4.  Fluorescence In situ Hybridization: Cell-Based Genetic Diagnostic and Research Applications.

Authors:  Chenghua Cui; Wei Shu; Peining Li
Journal:  Front Cell Dev Biol       Date:  2016-09-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.